Statistics for Final survival analysis of topotecan and paclitaxel for first-line treatment of advanced cervical cancer: An NRG oncology randomized study
Total visits
| views | |
|---|---|
| Final survival analysis of topotecan and paclitaxel for first-line treatment of advanced cervical cancer: An NRG oncology randomized study | 2 |
Total visits per month
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
File Visits
| views | |
|---|---|
| java.util.UUID:e007a34c-5b06-42e2-a05d-f43b431d26a2 | 43 |
| java.util.UUID:11e4147f-dda7-42cc-b725-76b0c876553a | 12 |
| java.util.UUID:530b7265-c448-44a1-8f8e-5a1a10ed1923 | 12 |
| nihms-1907473.pdf | 7 |
Top country views
| views | |
|---|---|
| United States | 2 |
Top city views
| views | |
|---|---|
| Franklin | 2 |